T-Box Genes in Vertebrate Development

Annual Review of Genetics - Tập 39 Số 1 - Trang 219-239 - 2005
L.A. Naiche1, Zachary Harrelson2,3, Robert G. Kelly2,4, Virginia E. Papaioannou2,3
1Department of Genetics and Development, College of Physicians and Surgeons, of Columbia University, New York, New York 10032, USA
2Department of Genetics and Development, College of Physicians and Surgeons of Columbia University, New York, New York 10032
3Institut de Biologie du Developpement de Marseille
4Developmental Biology Institute of Marseilles, Campus de Luminy Case 907, 13288 Marseille Cedex 9, France;

Tóm tắt

The myriad developmental roles served by the T-box family of transcription factor genes defy easy categorization. Present in all metazoans, the T-box genes are involved in early embryonic cell fate decisions, regulation of the development of extraembryonic structures, embryonic patterning, and many aspects of organogenesis. They are unusual in displaying dosage sensitivity in most instances. In humans, mutations in T-box genes are responsible for developmental dysmorphic syndromes, and several T-box genes have been implicated in neoplastic processes. T-box transcription factors function in many different signaling pathways, notably bone morphogenetic protein and fibroblast growth factor pathways. The few downstream target genes that have been identified indicate a wide range of downstream effectors.

Từ khóa


Tài liệu tham khảo

10.1242/dev.00191

Agulnik SI, 1996, Genetics, 144, 249, 10.1093/genetics/144.1.249

10.1006/geno.1998.5278

10.1016/S0140-6736(03)14671-5

10.1038/ng0797-311

Bärlund M, 2000, Cancer Res., 60, 5340

10.1038/ng0197-30

Beddington RSP, 1992, Development, 157, 10.1242/dev.116.Supplement.157

10.1016/S0925-4773(02)00040-0

10.1086/421331

10.1038/ng730

10.1242/dev.00763

10.1016/S0168-9525(02)02686-0

10.1006/dbio.1999.9298

10.1016/S0092-8674(01)00493-7

10.1016/S0896-6273(00)80647-9

10.1073/pnas.0401025101

10.1101/gad.300104

10.1242/dev.01832

10.1371/journal.pbio.0020003

10.1093/hmg/10.21.2403

10.1128/MCB.18.9.5099

10.1006/dbio.1996.0326

10.1016/S0925-4773(03)00066-2

10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F

10.1038/35624

10.1002/dvdy.10487

10.1016/S0969-2126(02)00722-0

Conlon FL, 2001, Development, 128, 3749, 10.1242/dev.128.19.3749

10.1242/dev.00431

Dheen T, 1999, Development, 126, 2703, 10.1242/dev.126.12.2703

Dobrovolskaia-Zavadskaia N, 1927, C. R. Acad. Sci. Biol., 97, 114

10.1074/jbc.M208120200

10.1126/science.1065544

10.1073/pnas.241508898

10.1093/hmg/10.22.2549

10.1038/nature01827

10.1093/hmg/10.18.1983

10.1016/0925-4773(96)00514-X

Gibson-Brown JJ, 1998, Development, 125, 2499, 10.1242/dev.125.13.2499

10.1038/nri1490

10.1073/pnas.1633548100

10.1101/gad.222902

10.1007/s00427-004-0415-3

10.1016/S0925-4773(02)00196-X

10.1242/dev.01378

10.1002/dvdy.10260

10.1016/S1043-4682(05)80009-1

10.1016/S0896-6273(01)00211-2

10.1038/90123

10.1016/j.cardiores.2004.01.030

10.1038/35005118

10.1242/dev.01399

10.1038/81583

10.1038/85845

Jerome-Majewska LA, Jenkins GP, Ernstoff E, Zindy F, Sherr CJ, Papaioannou VE. 2005. Tbx3, the ulnar mammary syndrome gene, andTbx2interact in mammary gland development through a p19Arf/p53-independent pathway. Dev. Dyn. In press

10.1084/jem.20031873

10.1093/hmg/ddh304

10.1016/S1044-5781(06)80003-4

10.1002/j.1460-2075.1993.tb05990.x

10.1016/S0925-4773(00)00494-9

10.1016/j.ydbio.2004.05.024

10.1101/gad.213002

10.1016/S0092-8674(01)00282-3

Lanctot C, 1997, Development, 124, 2807, 10.1242/dev.124.14.2807

10.1093/hmg/ddh176

10.1038/35065105

10.1074/jbc.M200403200

10.1073/pnas.141234898

10.1002/gcc.10122

10.1074/jbc.M305626200

10.1136/jmg.2003.010868

10.1016/j.devcel.2004.11.013

10.1038/39929

10.1242/dev.00504

10.1084/jem.20011956

10.1038/ng899

10.1016/S0074-7696(01)07002-4

Papaioannou VE, 2003, Inborn Errors of Development. The Molecular Basis of Clinical Disorders of Morphogenesis. Oxford Monogr. Med. Genet. No. 49, 686

10.1016/S0014-5793(97)00506-1

10.1016/S0378-1119(01)00878-2

10.1126/science.1090148

10.1073/pnas.082114899

10.1158/0008-5472.CAN-03-3401

10.1242/dev.00704

10.1158/0008-5472.CAN-03-3286

10.1101/gad.1065603

10.1101/gad.1065703

10.1242/dev.01067

10.1242/dev.00473

10.1038/19769

10.1038/35003601

10.1242/dev.00345

10.1007/s00439-004-1146-2

10.1002/(SICI)1097-0177(199706)209:2<242::AID-AJA10>3.0.CO;2-0

10.1073/pnas.85.1.180

10.1002/dvdy.10480

Sinclair CS, 2002, Cancer Res., 62, 3587

10.1016/j.mod.2004.10.011

10.1242/dev.01854

10.1016/S0378-1119(00)00417-0

10.1016/S0012-1606(03)00385-3

10.1242/dev.01799

10.1002/jcb.20039

10.1016/S1534-5807(03)00401-5

10.1016/S0092-8674(00)80702-3

10.1146/annurev.immunol.21.120601.140942

10.1126/science.1065543

10.1038/19762

10.1242/dev.00797

10.1242/dev.00474

10.1016/j.ydbio.2003.12.036

Vance KW, Carreira S, Brosch G, Goding CR. 2005. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res. 65: In press

10.1093/hmg/11.8.915

Vitelli F, 2002, Development, 129, 4605, 10.1242/dev.129.19.4605

10.1093/hmg/ddg216

10.1016/S0896-6273(04)00139-4

10.1016/S0925-4773(02)00394-5

10.1242/dev.00367

Xanthos JB, 2001, Development, 128, 167, 10.1242/dev.128.2.167

10.1242/dev.01174

10.1006/dbio.2000.9927

10.1101/gad.1048903

10.1006/geno.1998.5632

10.1016/j.gene.2004.01.017